UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Self-reported Gastrointestinal Side Effects of Antifibrotic Drugs in Dutch Idiopathic Pulmonary Fibrosis patients

Lung, 2019-10, Vol.197 (5), p.551-558

2019

Volltextzugriff (PDF)

Ranking Self-reported Gastrointestinal Side Effects of Pharmacotherapy in Sarcoidosis

Lung, 2020-04, Vol.198 (2), p.395-403

2020

Volltextzugriff (PDF)

POS0648 SURVIVAL ANALYSIS OF TIME TO FIRST ADVERSE DRUG REACTION AND DRUG SURVIVAL IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH METHOTREXATE AND HYDROXYCHLOROQUINE MONOTHERAPIES OR COMBINATION THERAPY

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.562-563

2021

Volltextzugriff (PDF)

Real‐world reported adverse events related to systemic immunomodulating therapy in patients with atopic dermatitis: Results from the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry

Journal of the European Academy of Dermatology and Venereology, 2024-03, Vol.38 (3), p.530-542

2024

Volltextzugriff (PDF)

Clindamycin-induced acute generalised exanthematous pustulosis: five cases and a review of the literature

Netherlands journal of medicine, 2016-12, Vol.74 (10), p.421-428

2016

Volltextzugriff (PDF)

Adverse events of haloperidol for the treatment of delirium in critically ill children

Intensive care medicine, 2014-10, Vol.40 (10), p.1602-1603

2014

Volltextzugriff (PDF)

POS0648 SEX DIFFERENCES IN ADVERSE DRUG REACTIONS FROM BIOLOGICAL USE IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.595-596

2022

Volltextzugriff (PDF)

Prosthetic infections following tocilizumab treatment in patients with rheumatoid arthritis

Rheumatology (Oxford, England), 2024-04

2024

Volltextzugriff (PDF)

Evaluation of electronic screening in the preoperative process

Journal of clinical anesthesia, 2022-11, Vol.82, p.110941-110941, Article 110941

2022

Volltextzugriff (PDF)

The observed respiratory rate of ward patients in the postoperative period

Journal of clinical anesthesia, 2022-02, Vol.76, p.110578-110578, Article 110578

2022

Volltextzugriff (PDF)

POS0651 IMPACT OF ADVERSE DRUG REACTIONS ON THE TREATMENT PATHWAYS OF EARLY RHEUMATOID ARTHRITIS PATIENTS

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.597-597

2022

Volltextzugriff (PDF)

AB0254 NEUROPSYCHIATRIC ADVERSE DRUG REACTIONS ASSOCIATED WITH LOW DOSE METHOTREXATE IN RHEUMATOID ARTHRITIS PATIENTS

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.1153-1153

2021

Volltextzugriff (PDF)

POS0620 TREATMENT PATHWAYS OF RHEUMATOID ARTHRITIS PATIENTS LEADING TO BIOLOGIC THERAPY VISUALIZED IN A SANKEY DIAGRAM

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.547-548

2021

Volltextzugriff (PDF)

POS0289 A CONCEPTUAL FRAMEWORK OF THE COURSE AND TIMEFRAME OF PATIENT-REPORTED ADVERSE DRUG REACTIONS OF BIOLOGICS IN IMMUNE-MEDIATED INFLAMMATORY DISEASES

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.389-390

2022

Volltextzugriff (PDF)

POS1563-PARE SELF-MANAGEMENT STRATEGIES FOR ADVERSE DRUG REACTIONS AS REPORTED BY TNF-ALPHA INHIBITOR USERS: AN OBSERVATIONAL STUDY

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.1127-1128

2022

Volltextzugriff (PDF)

THU0637-HPR THE ASSOCIATION BETWEEN THE RECALL PERIOD AND THE AMOUNT OF INFORMATION ABOUT REPORTED ADVERSE DRUG REACTIONS BY PATIENTS USING BIOLOGICALS

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.563-564

2020

Volltextzugriff (PDF)

THU0173 DIFFERENCES BETWEEN PATIENT-REPORTED AND PHYSICIAN-REPORTED ADVERSE DRUG REACTIONS ATTRIBUTED TO BDMARDS

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.302-302

2020

Volltextzugriff (PDF)

AB0196 SURVIVAL ANALYSIS OF TIME TO FIRST ADVERSE DRUG REACTION AND DRUG SURVIVAL IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ADALIMUMAB AND ETANERCEPT

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.1122-1122

2021

Volltextzugriff (PDF)

POS1532-HPR SEX DIFFERENCES IN THE EXPERIENCED BURDEN OF ADVERSE DRUG REACTIONS ATTRIBUTED TO ADALIMUMAB AND ETANERCEPT BY PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.1111-1111

2022

Volltextzugriff (PDF)

POS0355-PARE LONGITUDINAL INVESTIGATION AND VISUALIZATION OF COURSE AND BURDEN OF ADVERSE DRUG REACTIONS IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES USING TNFα INHIBITORS

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.430-431

2022

Volltextzugriff (PDF)

POS1531-HPR PATIENT-REPORTED ADVERSE DRUG REACTIONS ATTRIBUTED TO THE USE OF ETANERCEPT: DISTINCTION BASED ON NATURE, FREQUENCY AND BURDEN

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.1110-1110

2022

Volltextzugriff (PDF)

AB1548-HPR PATIENT-REPORTED ADVERSE DRUG REACTIONS ATTRIBUTED TO THE USE OF ADALIMUMAB: DISTINCTION BASED ON NATURE, FREQUENCY AND BURDEN

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.1875-1875

2022

Volltextzugriff (PDF)

POS0669 HYPOGLYCAEMIA FOLLOWING JAK INHIBITOR TREATMENT IN DIABETES MELLITUS PATIENTS WITH RHEUMATOID ARTHRITIS

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.578-579

2021

Volltextzugriff (PDF)

POS0271-HPR PATIENT PERSPECTIVE ON A DRUG SAFETY MONITORING SYSTEM FOR IMMUNE-MEDIATED INFLAMMATORY DISEASES BASED ON PATIENT-REPORTED OUTCOMES

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.359-359

2021

Volltextzugriff (PDF)

Advanced Age and Female Sex As Risk Factors for High Anion Gap Metabolic Acidosis After a Drug Interaction Between Paracetamol and Flucloxacillin: A Case Series

Journal of the American Geriatrics Society (JAGS), 2016-10, Vol.64 (10), p.e90-e93

2016

Volltextzugriff (PDF)

1 – 25 von 106

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(86)
Mit Volltextzugriff
(74)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Self-reported Gastrointestinal Side Effects of Antifibrotic Drugs in Dutch Idiopathic Pulmonary Fibrosis patients

Ranking Self-reported Gastrointestinal Side Effects of Pharmacotherapy in Sarcoidosis

POS0648 SURVIVAL ANALYSIS OF TIME TO FIRST ADVERSE DRUG REACTION AND DRUG SURVIVAL IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH METHOTREXATE AND HYDROXYCHLOROQUINE MONOTHERAPIES OR COMBINATION THERAPY

Real‐world reported adverse events related to systemic immunomodulating therapy in patients with atopic dermatitis: Results from the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry

Clindamycin-induced acute generalised exanthematous pustulosis: five cases and a review of the literature

Adverse events of haloperidol for the treatment of delirium in critically ill children

POS0648 SEX DIFFERENCES IN ADVERSE DRUG REACTIONS FROM BIOLOGICAL USE IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES

Prosthetic infections following tocilizumab treatment in patients with rheumatoid arthritis

Evaluation of electronic screening in the preoperative process

The observed respiratory rate of ward patients in the postoperative period

POS0651 IMPACT OF ADVERSE DRUG REACTIONS ON THE TREATMENT PATHWAYS OF EARLY RHEUMATOID ARTHRITIS PATIENTS

AB0254 NEUROPSYCHIATRIC ADVERSE DRUG REACTIONS ASSOCIATED WITH LOW DOSE METHOTREXATE IN RHEUMATOID ARTHRITIS PATIENTS

POS0620 TREATMENT PATHWAYS OF RHEUMATOID ARTHRITIS PATIENTS LEADING TO BIOLOGIC THERAPY VISUALIZED IN A SANKEY DIAGRAM

POS0289 A CONCEPTUAL FRAMEWORK OF THE COURSE AND TIMEFRAME OF PATIENT-REPORTED ADVERSE DRUG REACTIONS OF BIOLOGICS IN IMMUNE-MEDIATED INFLAMMATORY DISEASES

POS1563-PARE SELF-MANAGEMENT STRATEGIES FOR ADVERSE DRUG REACTIONS AS REPORTED BY TNF-ALPHA INHIBITOR USERS: AN OBSERVATIONAL STUDY

THU0637-HPR THE ASSOCIATION BETWEEN THE RECALL PERIOD AND THE AMOUNT OF INFORMATION ABOUT REPORTED ADVERSE DRUG REACTIONS BY PATIENTS USING BIOLOGICALS

THU0173 DIFFERENCES BETWEEN PATIENT-REPORTED AND PHYSICIAN-REPORTED ADVERSE DRUG REACTIONS ATTRIBUTED TO BDMARDS

AB0196 SURVIVAL ANALYSIS OF TIME TO FIRST ADVERSE DRUG REACTION AND DRUG SURVIVAL IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ADALIMUMAB AND ETANERCEPT

POS1532-HPR SEX DIFFERENCES IN THE EXPERIENCED BURDEN OF ADVERSE DRUG REACTIONS ATTRIBUTED TO ADALIMUMAB AND ETANERCEPT BY PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES

POS0355-PARE LONGITUDINAL INVESTIGATION AND VISUALIZATION OF COURSE AND BURDEN OF ADVERSE DRUG REACTIONS IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES USING TNFα INHIBITORS

POS1531-HPR PATIENT-REPORTED ADVERSE DRUG REACTIONS ATTRIBUTED TO THE USE OF ETANERCEPT: DISTINCTION BASED ON NATURE, FREQUENCY AND BURDEN

AB1548-HPR PATIENT-REPORTED ADVERSE DRUG REACTIONS ATTRIBUTED TO THE USE OF ADALIMUMAB: DISTINCTION BASED ON NATURE, FREQUENCY AND BURDEN

POS0669 HYPOGLYCAEMIA FOLLOWING JAK INHIBITOR TREATMENT IN DIABETES MELLITUS PATIENTS WITH RHEUMATOID ARTHRITIS

POS0271-HPR PATIENT PERSPECTIVE ON A DRUG SAFETY MONITORING SYSTEM FOR IMMUNE-MEDIATED INFLAMMATORY DISEASES BASED ON PATIENT-REPORTED OUTCOMES

Advanced Age and Female Sex As Risk Factors for High Anion Gap Metabolic Acidosis After a Drug Interaction Between Paracetamol and Flucloxacillin: A Case Series

Suchergebnisse filtern